Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Cabane

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
La Revue Du Praticien|January 21, 2003
[Living with scleroderma]Jean Cabane
Presse Medicale (Paris, France : 1983)|December 13, 2006
[Classification criteria of scleroderma]Jean Cabane,
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 14, 2010
Relevant criteria for selecting an intravenous immunoglobulin preparation for clinical usePatrick Chérin, Jean Cabane
Autoimmunity Reviews|July 6, 2010
Digestive tract involvement in systemic sclerosisKiet Phong Tiev, Jean Cabane
Presse Medicale (Paris, France : 1983)|April 30, 2010
[A diseased esophagus is frequently the cause of chronic hiccup. A prospective study of 184 cases]Jean Cabane, Jean-Louis Bizec, Jean-Philippe Derenne
Drug Safety|September 18, 2007
Corticosteroid-induced adverse events in adults: frequency, screening and preventionLaurence Fardet, Abdulrhaman Kassar, Jean Cabane, et al.
Annales De Medecine Interne|September 10, 2002
[Scleroderma and pregnancy]Monsef Rabhi, Kiet Phuong Tiev, Thierry Genereau, et al.
The Journal of Rheumatology|September 3, 2011
Combined pulmonary fibrosis and emphysema syndrome in a patient age 28 years with severe systemic sclerosisVincent Cottin, Nathalie Freymond, Jean Cabane, et al.
European Journal of Internal Medicine|July 26, 2006
Visual loss mimicking a treated temporal arteritis relapsePascal Augustin, Thierry Généreau, Pascale Cervera, et al.
Rheumatology (Oxford, England)|July 30, 2013
Efficacy of imatinib mesylate in a case of Churg-Strauss syndrome: evidence for the pathogenic role of a tyrosine kinase?Laurence Josselin-Mahr, Anabelle Werbrouck-Chiraux, Laurent Garderet, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
La Revue Du Praticien|January 21, 2003
[Living with scleroderma]Jean Cabane
Presse Medicale (Paris, France : 1983)|December 13, 2006
[Classification criteria of scleroderma]Jean Cabane,
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 14, 2010
Relevant criteria for selecting an intravenous immunoglobulin preparation for clinical usePatrick Chérin, Jean Cabane
Autoimmunity Reviews|July 6, 2010
Digestive tract involvement in systemic sclerosisKiet Phong Tiev, Jean Cabane
Presse Medicale (Paris, France : 1983)|April 30, 2010
[A diseased esophagus is frequently the cause of chronic hiccup. A prospective study of 184 cases]Jean Cabane, Jean-Louis Bizec, Jean-Philippe Derenne
Drug Safety|September 18, 2007
Corticosteroid-induced adverse events in adults: frequency, screening and preventionLaurence Fardet, Abdulrhaman Kassar, Jean Cabane, et al.
Annales De Medecine Interne|September 10, 2002
[Scleroderma and pregnancy]Monsef Rabhi, Kiet Phuong Tiev, Thierry Genereau, et al.
The Journal of Rheumatology|September 3, 2011
Combined pulmonary fibrosis and emphysema syndrome in a patient age 28 years with severe systemic sclerosisVincent Cottin, Nathalie Freymond, Jean Cabane, et al.
European Journal of Internal Medicine|July 26, 2006
Visual loss mimicking a treated temporal arteritis relapsePascal Augustin, Thierry Généreau, Pascale Cervera, et al.
Rheumatology (Oxford, England)|July 30, 2013
Efficacy of imatinib mesylate in a case of Churg-Strauss syndrome: evidence for the pathogenic role of a tyrosine kinase?Laurence Josselin-Mahr, Anabelle Werbrouck-Chiraux, Laurent Garderet, et al.
Pageof 6